Science Explorer Back to mapMap

Most cited papers from Bionovo (United States)

What are the most cited papers from Bionovo (United States)?

The most cited paper from Bionovo (United States) is "In vitro anticancer activity of twelve Chinese medicinal herbs" (Mark Shoemaker, Bobbi Hamilton, Schanaz H. Dairkee et al., 2005), with 231 citations. Next come "Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist" (196) and "Regulation of specific target genes and biological responses by estrogen receptor subtype agonists" (106).

Showing 34 of 34 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 In vitro anticancer activity of twelve Chinese medicinal herbs Mark Shoemaker, Bobbi Hamilton, Schanaz H. Dairkee et al. · Phytotherapy Research Open access Jul 2005 231
2 Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist Jennifer E. Mersereau, Nitzan Levy, Richard E. Staub et al. · Molecular and Cellular Endocrinology Open access 27 Nov 2007 196
3 Regulation of specific target genes and biological responses by estrogen receptor subtype agonists Dale C. Leitman, Sreenivasan Paruthiyil, Omar I. Vivar et al. · Current Opinion in Pharmacology ReviewOpen access 15 Oct 2010 106
4 Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes Kristine E. Ensrud, Katie L. Stone, TERRI L. BLACKWELL et al. · Menopause The Journal of The North American Menopause Society Mar 2009 105
5 Estrogen Receptor β Binds to and Regulates Three Distinct Classes of Target Genes Omar I. Vivar, Xiaoyue Zhao, Elise F. Saunier et al. · Journal of Biological Chemistry Open access 20 Apr 2010 102
6 Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer Hope S. Rugo, Emma Shtivelman, Alejandra Perez et al. · Breast Cancer Research and Treatment 16 Nov 2006 100
7 A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer Alejandra Perez, Banu Arun, Debu Tripathy et al. · Breast Cancer Research and Treatment 6 Jan 2010 93
8 Reduction of MTT by aqueous herbal extracts in the absence of cells Mark Shoemaker, Isaac V. Cohen, Michael J. Campbell · Journal of Ethnopharmacology 12 Jun 2004 93
9 Timosaponin AIII Is Preferentially Cytotoxic to Tumor Cells through Inhibition of mTOR and Induction of ER Stress Frank W. King, Sylvia Fong, Chandi A Griffin et al. · PLoS ONE Open access 29 Sep 2009 81
10 Selective Activation of Estrogen Receptor-β Transcriptional Pathways by an Herbal Extract Aleksandra Čvoro, Sreenivasan Paruthiyil, Jeremy O. Jones et al. · Endocrinology Open access 9 Nov 2006 76
11 Drug and Cell Type-Specific Regulation of Genes with Different Classes of Estrogen Receptor β-Selective Agonists Sreenivasan Paruthiyil, Aleksandra Čvoro, Xiaoyue Zhao et al. · PLoS ONE Open access 16 Jul 2009 69
12 Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2 Sreenivasan Paruthiyil, Aleksandra Čvoro, Mary Ann Tagliaferri et al. · Breast Cancer Research and Treatment 30 Nov 2010 67
13 MF101, a selective estrogen receptor β modulator for the treatment of menopausal hot flushes Deborah G. Grady, George F. Sawaya, Karen Johnson et al. · Menopause The Journal of The North American Menopause Society May 2009 57
14 Identification and Analysis of the Active Phytochemicals from the Anti-Cancer Botanical Extract Bezielle Vivian Chen, Richard E. Staub, Scott Baggett et al. · PLoS ONE Open access 17 Jan 2012 50
15 Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS Vivian Chen, Richard E. Staub, Sylvia Fong et al. · PLoS ONE Open access 3 Feb 2012 46
16 Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells Sylvia Fong, Mark Shoemaker, Jaclyn Cadaoas et al. · Cancer Biology & Therapy Open access Apr 2008 44
17 Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements Lonnele J. Ball, Nitzan Levy, Xiaoyue Zhao et al. · Molecular and Cellular Endocrinology Open access 26 Nov 2008 37
18 CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation Vivian Chen, Emma Shtivelman · Cell Cycle Open access 15 Dec 2010 37
19 Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid Ruth A. Chu, Xiaoyue Zhao, Chandi A Griffin et al. · International Journal of Cancer Open access 21 Dec 2009 36
20 Tissue-Specific Regulation of Genes by Estrogen Receptors Dale C. Leitman, Sreenivasan Paruthiyil, Chaoshen Yuan et al. · Seminars in Reproductive Medicine 2012 32
21 Oxidative in Vitro Metabolism of Liquiritigenin, a Bioactive Compound Isolated from the Chinese Herbal Selective Estrogen β-Receptor Agonist MF101 René Kupfer, Leah A. Swanson, Sylvia Chow et al. · Drug Metabolism and Disposition Aug 2008 32
22 Estrogen Receptor β-Selective Agonists Stimulate Calcium Oscillations in Human and Mouse Embryonic Stem Cell-Derived Neurons Lili Zhang, Brigitte E. Blackman, Marcus D. Schonemann et al. · PLoS ONE Open access 27 Jul 2010 31
23 Bezielle (BZL101)‐induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: A combined proteomic and metabolomic study Jelena Klawitter, Jelena Klawitter, Jost Klawitter et al. · International Journal of Cancer Open access 3 Feb 2011 25
24 Unliganded estrogen receptor-β regulation of genes is inhibited by tamoxifen Nitzan Levy, Sreenivasan Paruthiyil, Xiaoyue Zhao et al. · Molecular and Cellular Endocrinology 9 Sep 2009 22
25 Estrogenic Plant Extracts Reverse Weight Gain and Fat Accumulation without Causing Mammary Gland or Uterine Proliferation Elise F. Saunier, Omar I. Vivar, Andrea Rubenstein et al. · PLoS ONE Open access 7 Dec 2011 12
26 Background Adjustment for DNA Microarrays Using a Database of Microarray Experiments Yunxia Sui, Xiaoyue Zhao, Terence Paul Speed et al. · Journal of Computational Biology Open access Nov 2009 11
27 CC3/TIP30 affects DNA damage repair Sylvia Fong, Frank W. King, Emma Shtivelman · BMC Cell Biology Open access 7 Apr 2010 10
28 Is a shorter hot flash diary just as good as a 7-day diary? Deborah G. Grady, Judith L. Macer, Margaret Kristof et al. · Menopause The Journal of The North American Menopause Society 29 Aug 2009 8
29 Clinically meaningful efficacy of a non-estrogen agent: re-analysis of phase-2 data evaluating MF101 Mary Ann Tagliaferri, Jennifer M. Creasman, Katherine A. Caygill et al. · Climacteric 18 Jan 2012 4
30 Norlignans from Anemarrhenae asphoeloides Displaying Selective Estrogen Beta (ER?) Activity Hsiu‐Wen Yang, Scott Baggett, Richard E. Staub et al. · Planta Medica Feb 2008 1
31 Structural Elucidation of Four Mono-methyl Isoflavone Analogs Scott Baggett, Ramesh Chimmani, Suetying Chow et al. · Planta Medica Feb 2008 1
32 Prioritizing Disease Genes and Understanding Disease Pathways Xiaoyue Zhao, Lilia M. Iakoucheva, Michael Q. Zhang · IGI Global eBooks Book chapter 2009 0
33 Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata D. Don, towards breast cancer cells Sylvia Fong, Mark Shoemaker, Jaclyn Cadaoas et al. · Molecular Cancer Therapeutics Nov 2007 0
34 Identification of a Novel Class of Estrogen Receptor b-Selective Compounds Jordan E. Jackson, Richard E. Staub, Scott Baggett et al. · Fertility and Sterility Open access Sep 2005 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.